These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38780865)

  • 1. Modulation of the Immunological Milieu in Acute Aneurysmal Subarachnoid Hemorrhage: The Potential Role of Monocytes Through CXCL10 Secretion.
    Sanchez S; Chimenti MS; Lu Y; Sagues E; Gudino A; Dier C; Hasan D; Samaniego EA
    Transl Stroke Res; 2024 May; ():. PubMed ID: 38780865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary results in the analysis of the immune response after aneurysmal subarachnoid hemorrhage.
    Roa JA; Sarkar D; Zanaty M; Ishii D; Lu Y; Karandikar NJ; Hasan DM; Ortega SB; Samaniego EA
    Sci Rep; 2020 Jul; 10(1):11809. PubMed ID: 32678268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune cells subpopulations in cerebrospinal fluid and peripheral blood of patients with Aneurysmal Subarachnoid Hemorrhage.
    Moraes L; Grille S; Morelli P; Mila R; Trias N; Brugnini A; LLuberas N; Biestro A; Lens D
    Springerplus; 2015; 4():195. PubMed ID: 25977890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demographic, circadian, and climatic factors in non-aneurysmal versus aneursymal subarachnoid hemorrhage.
    Miranpuri AS; Aktüre E; Baggott CD; Miranpuri A; Uluç K; Güneş VE; Lin Y; Niemann DB; Başkaya MK
    Clin Neurol Neurosurg; 2013 Mar; 115(3):298-303. PubMed ID: 22770541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-Evaluating Risk Factors, Incidence, and Outcome of Aneurysmal and Non-Aneurysmal Subarachnoid Hemorrhage.
    Mortazavi ZS; Zandifar A; Ub Kim JD; Tierradentro-García LO; Shakarami M; Zamharir FD; Hadipour M; Oustad M; Shafiei E; Tara SZ; Shirani P; Asadi H; Vossough A; Saadatnia M
    World Neurosurg; 2023 Jul; 175():e492-e504. PubMed ID: 37024083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Subgroups in Subarachnoid Hemorrhage and Their Association With Outcomes-A Systematic Review and Meta-Regression.
    Wang MD; Fu QH; Song MJ; Ma WB; Zhang JH; Wang ZX
    Front Aging Neurosci; 2020; 12():573454. PubMed ID: 33505300
    [No Abstract]   [Full Text] [Related]  

  • 7. Elevated level of cerebrospinal fluid and systemic chemokine CCL5 is a predictive biomarker of clinical outcome after aneurysmal subarachnoid hemorrhage (aSAH).
    Chaudhry SR; Kinfe TM; Lamprecht A; Niemelä M; Dobreva G; Hänggi D; Muhammad S
    Cytokine; 2020 Sep; 133():155142. PubMed ID: 32485621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-Related Quality-of-Life Outcomes: Comparing Patients With Aneurysmal and Nonaneurysmal Subarachnoid Hemorrhage.
    McIntosh AP; Thomas A
    J Neurosci Nurs; 2015 Oct; 47(5):E2-11. PubMed ID: 26348436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of Risk Factors for Poor Prognosis of Non-Traumatic Non-Aneurysmal Subarachnoid Hemorrhage.
    Yuan Y; Chen J; Zhang Y; Zhao F; Zhai Y; Xu X; Xue L; Zhao Y; Wang H
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Characterization in Aneurysmal Subarachnoid Hemorrhage Reveals Distinct Monocytic Activation and Chemokine Patterns.
    Mohme M; Sauvigny T; Mader MM; Schweingruber N; Maire CL; Rünger A; Ricklefs F; Regelsberger J; Schmidt NO; Westphal M; Lamszus K; Tolosa E; Czorlich P
    Transl Stroke Res; 2020 Dec; 11(6):1348-1361. PubMed ID: 31858408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis Use and Increased Nonaneurysmal Subarachnoid Hemorrhage in the Past Decade.
    Lai PMR; Ng I; Gormley WB; Patel N; Frerichs KU; Aziz-Sultan MA; Du R
    World Neurosurg; 2021 Oct; 154():e580-e589. PubMed ID: 34325028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Systemic IL-6 Levels in Patients with Aneurysmal Subarachnoid Hemorrhage Is an Unspecific Marker for Post-SAH Complications.
    Chaudhry SR; Stoffel-Wagner B; Kinfe TM; Güresir E; Vatter H; Dietrich D; Lamprecht A; Muhammad S
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194369
    [No Abstract]   [Full Text] [Related]  

  • 13. Temporal Immune Profiling in the CSF and Blood of Patients with Aneurysmal Subarachnoid Hemorrhage.
    Ujas TA; Anderson KL; Lutshumba J; Hart SN; Turchan-Cholewo J; Hatton KW; Bachstetter AD; Nikolajczyk BS; Stowe AM
    medRxiv; 2024 Aug; ():. PubMed ID: 39228728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing numbers of nonaneurysmal subarachnoid hemorrhage in the last 15 years: antithrombotic medication as reason and prognostic factor?
    Konczalla J; Kashefiolasl S; Brawanski N; Senft C; Seifert V; Platz J
    J Neurosurg; 2016 Jun; 124(6):1731-7. PubMed ID: 26566212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodepression after aneurysmal subarachnoid hemorrhage.
    Sarrafzadeh A; Schlenk F; Meisel A; Dreier J; Vajkoczy P; Meisel C
    Stroke; 2011 Jan; 42(1):53-8. PubMed ID: 21088239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated cerebrospinal fluid levels of thrombospondin-1 correlate with adverse clinical outcome in patients with aneurysmal subarachnoid hemorrhage.
    Chen Q; Ye ZN; Liu JP; Zhang ZH; Zhou CH; Wang Y; Hang CH
    J Neurol Sci; 2016 Oct; 369():126-130. PubMed ID: 27653877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid untargeted metabolomic profiling of aneurysmal subarachnoid hemorrhage: an exploratory study.
    Lu AY; Damisah EC; Winkler EA; Grant RA; Eid T; Bulsara KR
    Br J Neurosurg; 2018 Dec; 32(6):637-641. PubMed ID: 30585503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the key immune-related genes in aneurysmal subarachnoid hemorrhage.
    Wang X; Wen D; You C; Ma L
    Front Mol Neurosci; 2022; 15():931753. PubMed ID: 36172261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Soluble Urokinase Plasminogen Activator Receptor (suPAR) in the Context of Aneurysmal Subarachnoid Hemorrhage (aSAH)-A Prospective Observational Study.
    Schmidt TP; Albanna W; Weiss M; Veldeman M; Conzen C; Nikoubashman O; Blume C; Kluger DS; Clusmann H; Loosen SH; Schubert GA
    Front Neurol; 2022; 13():841024. PubMed ID: 35359651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute impairment of saccadic eye movements is associated with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Rowland MJ; Garry P; Westbrook J; Corkill R; Antoniades CA; Pattinson KTS
    J Neurosurg; 2017 Oct; 127(4):754-760. PubMed ID: 27935361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.